Alimera Sciences Inc - Company Profile

Powered by

All the sales intelligence you need on Alimera Sciences Inc in one solution.

$ $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Alimera Sciences Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Alimera Sciences Inc.

Back to companies

Alimera Sciences Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Alimera Sciences Inc (Alimera), a subsidiary of ANI Pharmaceuticals Inc, focuses on the development and commercialization of prescription ophthalmic retinal pharmaceuticals. The company’s products are Iluvien and Yutiq, which are fluocinolone acetonide intravitreal implants used for the treatment of diabetic macular edema and chronic non-infectious uveitis affecting the posterior segment of the eye. Iluvien is prescribed for the treatment of recurrent non-infectious uveitis affecting the posterior segment of the eye (NIU-PS); proliferative diabetic retinopathy (NPDR); wet and dry age-related macular degeneration (AMD) and retinal vein occlusion. Yutiq is prescribed for the treatment of chronic NIU-PS. The company distributes its products in France, Austria, Portugal, the Czech Republic, Denmark, Finland, Germany, Spain, the UK, and others. Alimera is headquartered in Alpharetta, Georgia, the US.

 Gain a 360-degree view of Alimera Sciences Inc and make more informed decisions for your business Gain a 360-degree view of Alimera Sciences Inc and make more informed decisions for your business Learn more
Headquarters United States of America
Address Suite 400, 6310 Town Square, Alpharetta, Georgia, 30005
Website www.alimerasciences.com
Telephone 1 678 9905740
No of Employees 159
Industry Pharmaceuticals and Healthcare
Revenue (2023) $80.8M
   
   
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Learn more

Alimera Sciences Inc premium industry data and analytics

20+

Clinical Trials

Determine Alimera Sciences Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

16+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Alimera Sciences Inc’s relevant decision makers and contact details.

5

Catalyst Calendar

Proactively evaluate Alimera Sciences Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

4

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

2

Pipeline Drugs

Identify which of Alimera Sciences Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

1

Sales & Consensus Forecasts

Understand the current and future drug revenue for Alimera Sciences Inc and assess market opportunity for new entrants with patient population 8-year forecasts.

1

Marketed Drugs

Understand Alimera Sciences Inc’s commercialized product portfolio to stay one step ahead of the market.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Alimera Sciences Inc’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
Intravitreal Implants Iluvein
Yutiq
Understand Alimera Sciences Inc portfolio and identify potential areas for collaboration Understand Alimera Sciences Inc portfolio and identify potential areas for collaboration Learn more
Image for loader

Competitor Comparison

Key Parameters Alimera Sciences Inc Regeneron Pharmaceuticals Inc Titan Pharmaceuticals Inc RegeneRx Biopharmaceuticals Inc Genentech Inc
Headquarters United States of America United States of America United States of America United States of America United States of America
City Alpharetta Tarrytown New York Rockville San Francisco
State/Province Georgia New York New York Maryland California
No. of Employees 159 15,410 4 2 12,100
Entity Type Private Public Private Public Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Learn more
Executives
Name Position Board Since Age
Richard Eiswirth Chief Executive Officer Senior Management - -
Elliot Maltz Chief Financial Officer Senior Management - -
Chris Visick Secretary Senior Management - -
Adam Morgan Director Non Executive Board - 46
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Alimera Sciences Inc key executives to enhance your sales strategy Gain insight into Alimera Sciences Inc key executives to enhance your sales strategy Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?